Contact Us

Scott Gottlieb: GLP-1 drugs are a profound medical advance on par with statins

Thought Leader: Scott Gottlieb
February 29, 2024
Source: CNBC

Dr. Scott Gottlieb, former FDA commissioner, joins ‘Power Lunch’ to discuss how big the GLP-1 drugs are likely to be, what could make the drugs hard for insurance not to pay for, and much more.

Subscribe to the WWSG newsletter.

Check Availability

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Speaker List
Share My List